Free Trial

Blueprint Medicines (BPMC) SEC Filings & 10K Form

Blueprint Medicines logo
$128.27 +0.07 (+0.05%)
Closing price 07/3/2025 02:27 PM Eastern
Extended Trading
$128.27 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Blueprint Medicines SEC Filings

DateFilerForm TypeView
06/24/2025
3:23 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:24 PM
Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:25 PM
Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:26 PM
Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:28 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
7:04 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2025
6:06 AM
Blueprint Medicines (Subject)
Form SC 14D9
06/17/2025
5:07 AM
Blueprint Medicines (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T
06/05/2025
3:22 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
4:11 PM
Blueprint Medicines (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
06/02/2025
5:22 AM
Blueprint Medicines (Subject)
Form SC14D9C
06/02/2025
5:09 AM
Blueprint Medicines (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
06/02/2025
5:13 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
8:06 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025
3:33 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
8:30 AM
Avoro Capital Advisors LLC (Filed by)
Blueprint Medicines (Subject)
Form SCHEDULE 13G
05/12/2025
9:44 AM
Blueprint Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/05/2025
3:57 PM
Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
6:12 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2025
3:16 PM
Blueprint Medicines (Filer)
Form DEF 14A
04/24/2025
3:20 PM
Blueprint Medicines (Filer)
Form DEFA14A
04/23/2025
7:19 PM
BlackRock, Inc. (Filed by)
Blueprint Medicines (Subject)
Form SCHEDULE 13G/A
04/03/2025
3:30 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
3:27 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:04 PM
Blueprint Medicines (Subject)
Rossi Christina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:26 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:36 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:12 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:13 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:14 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:15 PM
Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:17 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:18 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:18 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:19 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:20 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:20 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:21 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:15 PM
Blueprint Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2025
4:09 PM
Blueprint Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)

Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.

We recently interviewed Rickards to get the full story and understand how everyday Americans can pre
02/13/2025
6:34 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
6:53 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
6:54 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
6:56 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:23 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
8:25 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:24 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
5:03 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
5:04 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:50 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
10:55 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:15 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:15 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
4:17 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:31 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
6:51 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
3:52 PM
Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
4:33 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
5:52 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
12:40 PM
Blueprint Medicines (Subject)
Haviland Kate (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
5:51 PM
Blueprint Medicines (Subject)
Rossi Christina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:47 PM
Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:23 PM
Blueprint Medicines (Subject)
COATS LONNEL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
12:44 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144/A
11/07/2024
4:24 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2024
3:27 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
6:07 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:09 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:06 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:22 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
3:27 PM
Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
4:06 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
3:50 PM
Blueprint Medicines (Subject)
Lee Philina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:48 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
6:29 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
6:07 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:08 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BPMC) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners